Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/14 16:22 | 5/5/14 | DGX | Health | Health | Medical Laboratories | Guinan Mark | NJ | O | SVP,CFO | P | 222 | 55.51 | 33 | 4 | 10 | 44 | D | -1 | -2 | -8 | 9 | 2 | -8 | -1 | -1 | 2 | 2 | 10 | 9 | 12 | 28 |
2/7/14 16:58 | 2/6/14 | DGX | Health | Health | Medical Laboratories | Main Timothy L | NJ | D | P | 254 | 50.71 | 33 | 5 | 760 | 6 | D | -10 | -10 | -11 | -18 | -6 | -7 | -4 | 0 | 2 | 3 | 4 | 13 | 19 | 40 | |
8/7/12 16:20 | 8/7/12 | DGX | Health | Health | Medical Laboratories | Rusckowski Stephen H | NJ | DO | P,CEO | P | 297 | 59.34 | 33 | 5 | 8 | 68 | D | 25 | 18 | 2 | 3 | 4 | -7 | 1 | 1 | 1 | 0 | 3 | -1 | 0 | 2 |
5/9/12 16:40 | 5/8/12 | DGX | Health | Health | Medical Laboratories | Rusckowski Stephen H | NJ | DO | P,CEO | P | 1,138 | 56.89 | 33 | 20 | 46 | 63 | D | 7 | 2 | 4 | -1 | -5 | -3 | 0 | -1 | 1 | 0 | -4 | 4 | 2 | 6 |
10/30/06 16:38 | 10/26/06 | DGX | Health | Health | Medical Laboratories | Stanzione Daniel | NJ | D | P | 50 | 49.74 | 33 | 1 | 12 | 10 | D | 16 | 9 | -9 | -17 | -19 | -1 | -1 | -2 | 0 | 0 | 3 | 6 | -1 | 8 | |
8/12/05 17:41 | 8/12/05 | DGX | Health | Health | Medical Laboratories | Bongiorno Thomas F | O | Controll | P.d | 111 | 50.64 | 33 | 2 | 57 | 6 | M | 73 | 24 | 2 | -5 | -5 | -2 | -2 | 2 | 0 | -1 | 3 | -3 | 4 | 24 | |
5/13/04 16:59 | 5/12/04 | DGX | Health | Health | Medical Laboratories | Flaherty James F III | NJ | D | P.m | 328 | 82.06 | 33 | 4 | 200 | 6 | M | -10 | 36 | 25 | -3 | 0 | -3 | -4 | -2 | 0 | -1 | 5 | -1 | 10 | 29 | |
8/7/03 17:06 | 8/6/03 | DGX | Health | Health | Medical Laboratories | Flaherty James F III | NJ | D | P | 115 | 57.56 | 33 | 2 | New | 2 | D | -17 | 0 | 12 | -6 | -9 | -12 | -6 | -2 | 1 | 2 | 5 | 18 | 47 | 39 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |